INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 49m ago
House PTR9m ago
SEC 13F9m ago
Robinhood Chain9m ago

Results

20,303 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
20
0xa855…3c74Wallet
SLViShares Silver Trust
Burn / redemption
SELL$52K
1,094 sh
Nov 4, 2026Nov 4, 22:16 UTC
traded Nov 4, 2026
onchainRobinhood Chain

Evidence

Page 19 of 508
← PrevNext →
17
0xa855…3c74Wallet
USOUnited States Oil Fund, LP
Burn / redemption
SELL
$38K
261 sh
Nov 4, 2026
Nov 4, 22:15 UTC
traded Nov 4, 2026
onchain
Robinhood Chain

Evidence

20
0xa855…3c74Wallet
USOUnited States Oil Fund, LP
Burn / redemption
SELL$75K
519 sh
Nov 4, 2026Nov 4, 22:15 UTC
traded Nov 4, 2026
onchainRobinhood Chain

Evidence

53
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$6.83M
7,073 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

49
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$2.58M
2,670 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

49
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$1.47M
1,522 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

49
GL
Garceau Mary LSVP - CLO and Secretary
SHWSHERWIN WILLIAMS CO
Open-market sale
SELL$1.36M
3,891 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

49
WL
Way T LawrenceDirector
CUBICustomers Bancorp, Inc.
Open-market sale
SELL$4.09M
48.8K sh
Oct 30, 2026Nov 4, 2026
traded Oct 30, 2026
+5dSEC Form 4

Evidence

49
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$4.18M
4,338 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

49
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$2.43M
2,522 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

49
LJ
Larosa Joseph JEVP General Counsel and Secret
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$3.80M
3,939 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

47
SM
Skeete Bernard MChief Accounting Officer
VLTOVeralto Corp
Open-market sale
SELL$170K
1,514 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

45
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$1.01M
1,040 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

45
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$1.18M
1,224 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

45
PM
Pope Daniel MDirector
TYLTYLER TECHNOLOGIES INC
Open-market sale
SELL$277K
680 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

44
CC
Clay CraigSenior Advisor
DFINDonnelley Financial Solutions, Inc.
Open-market sale
SELL$1.45M
21.4K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

44
TJ
Treff Douglas JDirector
CROXCrocs, Inc.
Open-market sale
SELL$1.10M
7,185 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

44
CC
Clay CraigSenior Advisor
DFINDonnelley Financial Solutions, Inc.
Open-market sale
SELL$1.45M
21.5K sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

44
CC
Clay CraigSenior Advisor
DFINDonnelley Financial Solutions, Inc.
Open-market sale
SELL$1.89M
28.1K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

43
BG
Bichara GuillermoExec VP & Chief Legal Officer
LINLINDE PLC
Open-market sale
SELL$4.85M
9,350 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

42
LJ
Larosa Joseph JEVP General Counsel and Secret
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$509K
527 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

42
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$519K
540 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

42
MM
Murphy Robert MadisonDirector
MUSAMurphy USA Inc.
Open-market sale
SELL$589K
1,000 sh
May 4, 2026Nov 4, 2026
traded May 4, 2026
+184dSEC Form 4

Evidence

41
TK
Turner KamiChief Accounting Officer
DFINDonnelley Financial Solutions, Inc.
Open-market sale
SELL$406K
6,000 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

41
TK
Turner KamiChief Accounting Officer
DFINDonnelley Financial Solutions, Inc.
Open-market sale
SELL$406K
6,100 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

40
OS
Olschan Brian SDirector, President and COO
ACUACME UNITED CORP
Open-market sale
SELL$982K
14.2K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

39
HR
Heyer Andrew RDirector
OSWONESPAWORLD HOLDINGS Ltd
Open-market sale
SELL$183K
7,000 sh
Aug 20, 2026Nov 4, 2026
traded Aug 20, 2026
+76dSEC Form 4

Evidence

39
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$194K
200 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

38
CM
Chybowski Joseph M.PRESIDENT & CFO
BWBBridgewater Bancshares Inc
Open-market sale
SELL$197K
9,651 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

38
MM
Murphy Robert MadisonDirector
MUSAMurphy USA Inc.
Open-market sale
SELL$624K
1,000 sh
Jul 29, 2026Nov 4, 2026
traded Jul 29, 2026
+98dSEC Form 4

Evidence

38
LR
Lindquist Scott REVP & CFO
CNACNA FINANCIAL CORP
Open-market sale
SELL$1.12M
23.6K sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

37
CC
Clay CraigSenior Advisor
DFINDonnelley Financial Solutions, Inc.
Open-market sale
SELL$309K
4,500 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

37
TJ
Treff Douglas JDirector
CROXCrocs, Inc.
Open-market sale
SELL$515K
3,416 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

37
TJ
Treff Douglas JDirector
CROXCrocs, Inc.
Open-market sale
SELL$471K
3,101 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

37
MH
Murphy Susan HDirector
ACUACME UNITED CORP
Open-market sale
SELL$194K
2,890 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

37
CC
Clay CraigSenior Advisor
DFINDonnelley Financial Solutions, Inc.
Open-market sale
SELL$986K
14.5K sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

36
PS
Pangali SanamChief Legal Officer
ALMSALUMIS INC.
Open-market sale
SELL$2,165
332 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

36
BM
Bitetti Teresa MariePresident, OBU
TAKTAKEDA PHARMACEUTICAL CO LTD
Open-market sale
SELL$974K
46.6K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

36
GM
Goldstein David MChief Scientific Officer
ALMSALUMIS INC.
Open-market sale
SELL$4,101
629 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

36
DJ
Drappa JornChief Medical Officer
ALMSALUMIS INC.
Open-market sale
SELL$3,866
593 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence